Background illustration for clinical trials search

Paid Clinical Trials New Mexico

Discover 322 paid clinical trials in New Mexico. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Augusta ME, Scarborough ME, South Portland ME,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06498635

Phase3, Recruiting

Molecular Genetics Studies of Cancer Patients and Their Relatives

for
Malignant Neoplasm
Location: Brighton MA, Mount Kisco NY, Poughkeepsie NY,
Sponsor: City of Hope Medical Center

Sex: All

Age: 0+

Code: NCT04185935

Recruiting

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

for
Triple-Negative Breast Cancer
Location: Halifax, Moncton, Rimouski, Farmington CT, New Haven CT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06393374

Phase3, Recruiting

A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis

for
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Location: Boston MA, East Providence RI, Lebanon NH,
Sponsor: Amgen

Sex: All

Age: 18 - 70+

Code: NCT06072482

Recruiting

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

for
Colorectal Neoplasms
Location: Shirley NY, New Haven CT, Mineola NY, The Bronx NY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06662786

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Generic Database of Very Low Birth Weight Infants

for
Infant, Newborn, Infant, Low Birth Weight,
Location: Philadelphia PA, Durham NC, Cleveland OH, Atlanta GA,
Sponsor: NICHD Neonatal Research Network

Sex: All

Age: 0

Code: NCT00063063

Recruiting

Bacterial Overgrowth Associated With Chronic Multisymptom Illness Complex

for
Gulf War Syndrome
Location: Albuquerque NM
Sponsor: Henry C. Lin, MD

Sex: All

Age: 21+

Code: NCT00956150

Phase1, Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Scarborough ME, Providence RI, New Haven CT, Mineola NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06824467

Phase3, Recruiting

The Synchrony Study: Examining Music Training for Children With FASD

for
Fetal Alcohol Spectrum Disorders
Location: Albuquerque NM
Sponsor: The Mind Research Network

Sex: All

Age: 8 - 16

Code: NCT06005181

Recruiting

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

for
Gestational Diabetes Mellitus, Pregnancy, High Risk
Location: Boston MA, Providence RI, New York NY, Philadelphia PA,
Sponsor: Ohio State University

Sex: Female

Age: 18+

Code: NCT06445946

Recruiting

Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy

for
Acute Myelogenous Leukemia
Location: Durham NC, Augusta GA, Houston TX, Albuquerque NM,
Sponsor: Hybrigenics Corporation

Sex: All

Age: 65+

Code: NCT02802267

Phase2, Recruiting

Control Network Neuromodulation to Enhance Cognitive Training in Complex Traumatic Brain Injury

for
Traumatic Brain Injury
Location: Minneapolis MN, Albuquerque NM
Sponsor: University of New Mexico

Sex: All

Age: 18 - 59

Code: NCT05236010

Recruiting

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

for
Stage III Ovarian Cancer, Stage IV Ovarian Cancer,
Location: Hartford CT, New Haven CT, New York NY, Teaneck NJ,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT05659381

Phase3, Recruiting

Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

for
Cutaneous Squamous Cell Carcinoma (CSCC)
Location: Beverly MA, Portsmouth NH, Boston MA, New York NY,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06585410

Phase3, Recruiting

Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment

for
Substance-Related Disorders, Treatment Adherence
Location: Albuquerque NM
Sponsor: University of New Mexico

Sex: All

Age: 18+

Code: NCT05489068

Recruiting

Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN

for
IC-MPGN
Location: Boston MA, New York NY, Montreal, Philadelphia PA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 12 - 60

Code: NCT05755386

Phase3, Recruiting

Multimodal Image Analysis and Guidance of Neuromodulation for Trauma-Related Symptoms

for
Posttraumatic Stress Disorder
Location: Albuquerque NM
Sponsor: University of New Mexico

Sex: All

Age: 18 - 70+

Code: NCT06449326

Recruiting

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

for
Metastatic Breast Cancer
Location: Boston MA, New York NY, New Brunswick NJ, Montreal,
Sponsor: LeonaBio

Sex: All

Age: 18+

Code: NCT05696626

Phase3, Recruiting

Ketogenic Diet and Diabetes Demonstration Project

for
Type 2 Diabetes, PreDiabetes, Obesity, Ketogenic Dieting
Location: Albuquerque NM
Sponsor: University of New Mexico

Sex: All

Age: 18+

Code: NCT06115265

Recruiting

Amplitude Titration to Improve ECT Clinical Outcomes

for
Depression, ECT, Cognitive Change
Location: Albuquerque NM
Sponsor: University of New Mexico

Sex: All

Age: 50+

Code: NCT05699226

Recruiting

Popular cities in New Mexico